Vivus’s diet pill faces generic threat from Actavis
[Reuters] – Vivus Inc said on Friday drugmaker Actavis Plc plans to market a generic version of Vivus’s obesity drug Qsymia that was approved in July 2012. Actavis had filed a U.S. marketing application for its generic version of the diet pill, according moreView todays social media effects on ACTView the latest stocks trending across Twitter. Click to view dashboardSee […]